.
Treatment was begun with daily haemodialysis using a cuprophan membrane. This was tolerated poorly, with coughing fits, bronchospasm, hypotension and pyrexia with rigors which developed soon after commencing dialysis. After a week of haemodialysis, during which the eosinophil count rose to 50,000 x 109/l, the patient became drowsy and then increasingly encephalopathic. Peritoneal dialysis was substituted and pulsed methyl prednisolone commenced. He was transfused as the haemoglobin had fallen to 3.9g/dl. Thirty-six hours later he was making a remarkable recovery, the pyrexia had resolved and the eosinophil count had fallen precipitously. Urine output increased and after a week peritoneal dialysis could be discontinued (Figure 2 ). Oral prednisolone was cautiously reduced from 60mg/day and he was discharged 4 weeks after admission. Six weeks later the serum creatinine was 450pmol/l, close to the pre-ChurgStrauss episode. (1/day).
Discussion
This case of acute renal failure due to ChurgStrauss syndrome in an insulin-dependent diabetic acts as a reminder that not all cases of renal failure in diabetics are due to diabetic nephropathy. Churg-Strauss syndrome is a subtype of polyarteritis nodosa and mainly affects the renal vasculature although eosinophilic granuloma as in this case may also be present. Medium arteries, arterioles or glomeruli can be involved in a focal necrotizing arteritis resulting in small areas of infarction. Acute lesions are seen with areas of fibrinoid necrosis and thrombosis with intense inflammatory cell infiltration. Lesions heal resulting in vascular scarring or in the glomeruli scars within the tufts. Interstitial nephritis may typically occur without histological evidence of glomerular involve-ment. The interstitium may also show intense eosinophilic infiltration with the formation of eosinophilic granulomata. 4 This man had suffered with asthma for the 3 years in the prodromal phase of his illness without any record of blood or sputum eosinophilia, with negative skin tests. He then developed an aggressive vasculitic phase presenting in acute renal failure with pericarditis and lung involvement.5 He then became encephalopathic with an eosinophil count of 50,000 x 109/1, presumably a direct effect of the eosinophilia rather than a cerebral vasculitis. An eosinophil-derived neurotoxin has been described in cases of encephalopathy associated with the hypereosinophilia syndrome, although both major basic protein and eosinophilic cationic protein may also contribute to the neurological dysfunction.6 The rapid fall in haemoglobin has been noted previously in the active vasculitic phase. 7 The substantial rise in the peripheral eosinophil count over the first week of daily haemodialysis treatment was more likely related to the bioincompatibility of the dialyzer membrane used rather than an increase in the underlying disease activity. The adverse reactions noted during haemodialysis reflect the degree of complement activation and eosinophil degranulation associated with the use of cuprophan dialysis membranes.
Conclusions
We have described a rare case of acute renal failure associated with the aggressive vasculitic phase of Churg-Strauss syndrome. The patient required dialysis therapy for management of his acute renal failure and we believe that the use of a cuprophan dialyzer caused the activation of peripheral eosinophils resulting in the development of encephalopathy. Fortunately his condition responded to treatment with prednisolone.
In future we would recommend the use of either peritoneal dialysis or haemofiltration with a more bio-compatible membrane for the treatment of patients with acute renal failure due to CSS until renal function improves under the influence of steroids and immunosuppressants. 
